ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
TBCH
Turtle Beach Corporation
TBCH has a slight edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TBCH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Strong | |
| Weak |
TBCH's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
TBCH PE Valuation
TBCH has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
TBCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TBCH, with profitability improving. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
TBCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.16 | — |
| Q3 2026 | -$0.06 | -107% |
| Q2 2026 | -$0.22 | -123% |
| Q1 2026 | $0.02 | -97% |
| Q4 2025 | $0.77 | -1.3% |
| Q3 2025 | $0.87 | +200% |
| Q2 2025 | $0.95 | +$1.03 |
| Q1 2025 | $0.74 | +$1.40 |
| Q4 2024 | $0.78 | +$1.85 |
TBCH has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over TBCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
TBCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.7M | +5.3% |
| Q2 2026 | $56.4M | -0.7% |
| Q1 2026 | $42.2M | -34% |
| Q4 2025 | $118.8M | -19% |
| Q3 2025 | $80.5M | -15% |
| Q2 2025 | $56.8M | -26% |
| Q1 2025 | $63.9M | +14% |
| Q4 2024 | $146.1M | +47% |
TBCH's revenue is recovering but still below its 2024 peak: $85M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | +0.3 points |
| Q2 2026 | -5.4% | -4.8 points |
| Q1 2026 | -33% | -36 points |
| Q4 2025 | 18% | +1.6 points |
| Q3 2025 | 6.7% | -0.1 points |
| Q2 2025 | -0.6% | +4.8 points |
| Q1 2025 | 2.4% | +13 points |
| Q4 2024 | 16% | +7.6 points |
TBCH has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
TBCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.3M | +$8.5M |
| Q2 2026 | $5.9M | +$9.4M |
| Q1 2026 | $29.1M | -28% |
| Q4 2025 | $13.1M | +2.3% |
| Q3 2025 | -$15.9M | +$8.7M |
| Q2 2025 | -$3.5M | +$10.4M |
| Q1 2025 | $40.3M | +52% |
| Q4 2024 | $12.8M | -32% |
TBCH has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
TBCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.1% | -985K shares |
| 1 year | -11% | -2.2M shares |
| 3 years | +4.9% | +852K shares |
| 5 years | -0.8% | -138K shares |
| Available history | +16% | +2.5M shares |
TBCH has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $25M |
| Q1 2026 | $2.2M |
| Q4 2025 | $2M |
| Q3 2025 | $10.3M |
| Q2 2025 | $5M |
| Q1 2025 | $1.8M |
| Q4 2024 | $2.4M |
TBCH spent $29M buying back its own shares over the past year, up 50% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TBCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 4.7x | High |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.4x | Healthy |
TBCH's net debt is about 5.2 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
TBCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 76.0 | Neutral |
TBCH's weekly RSI is 64 (neutral) and its Stochastic is 76 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
TBCH PE vs Technology Sector
| Metric | TBCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
TBCH has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
TBCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 11% above |
| 20 week MA | $13.6 | 21% above |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $13.8 | 19% above |
| 200 week MA | $13.1 | 26% above |
TBCH has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
TBCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.91 | $24.7 | +178% |
| 2021 | $24.7 | $24.5 | -1.1% |
| 2022 | $24.5 | $6.99 | -71% |
| 2023 | $6.99 | $11.0 | +57% |
| 2024 | $11.0 | $16.9 | +55% |
| 2025 | $16.9 | $14.2 | -16% |
| 2026 YTD | $14.2 | $16.5 | +17% |
TBCH has the edge over ASTS on returns for 2026, with the stronger performance.